Tue, Oct
0 New Articles

Distributed orchestra plays in concert over 5G, conducted by ETSI’s Open Source MANO


Musicians across venues in Bristol and London recently performed a fully synchronised concert, underpinned by 5G.

The three-way distributed music performance connected musicians in three geographical areas over a 5G network, orchestrated by ETSI Open Source management and orchestration ( MANO).

ETSI calls the solution it used a “breakthrough”; it allows network operators to provide highly synchronised and low latency services across their high capacity and low throughput networks.

Musicians included Professor Mischa Dohler, from Kings College London, a 5G researcher and music composer. Professor Dohler performed a live composition from London’s Guildhall. Over the 5G network, he was accompanied in real-time by musicians based at London’s Digital Catapult. The team says the audience experience was exactly the same as if the musicians were performing in the same venue.



Open Source MANO

Standards body ETSI said the demonstration validates Open Source MANO (OSM) as a 5G service orchestrator. Open Source MANO is ETSI’s initiative to develop an open source NFV MANO software stack aligned with ETSI NFV.

The University of Bristol’s Smart Internet Lab has been working with the ETSI OSM community on the creation of an intelligent technology platform which enables automated composition of services across multiple 5G domains.

This collaboration crystallised in OSM Release FIVE with the delivery of the OSM's wide area infrastructure manager (WIM) Plug-in model, enabling the dynamic interconnection of remote sites, and deployment of services across them over different software-defined networking (SDN) technologies.

The concert took place as part of the 5G Smart Futures event in Bristol, which included demonstrations and discussions focused around the creative and economic potential of 5G.

The demonstration was also an output of the Smart Tourism project, which is funded by the UK Government’s 5GUK Testbeds and Trials Programme.